704 related articles for article (PubMed ID: 35740975)
21. Inhibition of M2-like macrophages by all-trans retinoic acid prevents cancer initiation and stemness in osteosarcoma cells.
Shao XJ; Xiang SF; Chen YQ; Zhang N; Cao J; Zhu H; Yang B; Zhou Q; Ying MD; He QJ
Acta Pharmacol Sin; 2019 Oct; 40(10):1343-1350. PubMed ID: 31296953
[TBL] [Abstract][Full Text] [Related]
22. The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology.
Vanmeerbeek I; Govaerts J; Laureano RS; Sprooten J; Naulaerts S; Borras DM; Laoui D; Mazzone M; Van Ginderachter JA; Garg AD
Cells; 2022 Dec; 11(23):. PubMed ID: 36497148
[TBL] [Abstract][Full Text] [Related]
23. VEGFA/NRP-1/GAPVD1 axis promotes progression and cancer stemness of triple-negative breast cancer by enhancing tumor cell-macrophage crosstalk.
Wang L; Zhang L; Zhao L; Shao S; Ning Q; Jing X; Zhang Y; Zhao F; Liu X; Gu S; Zhao X; Luo M
Int J Biol Sci; 2024; 20(2):446-463. PubMed ID: 38169627
[TBL] [Abstract][Full Text] [Related]
24. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
Safa AR
Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
[TBL] [Abstract][Full Text] [Related]
25. Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments.
Raghavan S; Mehta P; Xie Y; Lei YL; Mehta G
J Immunother Cancer; 2019 Jul; 7(1):190. PubMed ID: 31324218
[TBL] [Abstract][Full Text] [Related]
26. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
27. Tumor-associated macrophages derived from cancer stem cells.
Osman A; Oze M; Afify SM; Hassan G; El-Ghlban S; Nawara HM; Fu X; Zahra MH; Seno A; Winer I; Salomon DS; Seno M
Acta Histochem; 2020 Dec; 122(8):151628. PubMed ID: 32992123
[TBL] [Abstract][Full Text] [Related]
28. Microenvironment of Cancer Stem Cells.
Tanabe S
Adv Exp Med Biol; 2022; 1393():103-124. PubMed ID: 36587304
[TBL] [Abstract][Full Text] [Related]
29. Tumor-associated macrophages in liver cancer: From mechanisms to therapy.
Cheng K; Cai N; Zhu J; Yang X; Liang H; Zhang W
Cancer Commun (Lond); 2022 Nov; 42(11):1112-1140. PubMed ID: 36069342
[TBL] [Abstract][Full Text] [Related]
30. The Immunosuppressive Microenvironment in BRCA1-IRIS-Overexpressing TNBC Tumors Is Induced by Bidirectional Interaction with Tumor-Associated Macrophages.
Sami E; Paul BT; Koziol JA; ElShamy WM
Cancer Res; 2020 Mar; 80(5):1102-1117. PubMed ID: 31911557
[TBL] [Abstract][Full Text] [Related]
31. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic Approaches Targeting Proteins in Tumor-Associated Macrophages and Their Applications in Cancers.
Wu D; Liu X; Mu J; Yang J; Wu F; Zhou H
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327584
[TBL] [Abstract][Full Text] [Related]
33. Interaction of tumor-associated microglia/macrophages and cancer stem cells in glioma.
Zhu X; Fang Y; Chen Y; Chen Y; Hong W; Wei W; Tu J
Life Sci; 2023 May; 320():121558. PubMed ID: 36889666
[TBL] [Abstract][Full Text] [Related]
34. Tumor-associated macrophage derived IL-6 enriches cancer stem cell population and promotes breast tumor progression via Stat-3 pathway.
Radharani NNV; Yadav AS; Nimma R; Kumar TVS; Bulbule A; Chanukuppa V; Kumar D; Patnaik S; Rapole S; Kundu GC
Cancer Cell Int; 2022 Mar; 22(1):122. PubMed ID: 35300689
[TBL] [Abstract][Full Text] [Related]
35. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
Yadav AK; Desai NS
Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
[TBL] [Abstract][Full Text] [Related]
36. LSECtin on tumor-associated macrophages enhances breast cancer stemness via interaction with its receptor BTN3A3.
Liu D; Lu Q; Wang X; Wang J; Lu N; Jiang Z; Hao X; Li J; Liu J; Cao P; Peng G; Tao Y; Zhao D; He F; Tang L
Cell Res; 2019 May; 29(5):365-378. PubMed ID: 30858559
[TBL] [Abstract][Full Text] [Related]
37. Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.
Li YR; Fang Y; Lyu Z; Zhu Y; Yang L
J Transl Med; 2023 Oct; 21(1):686. PubMed ID: 37784157
[TBL] [Abstract][Full Text] [Related]
38. Cancer cells stemness: A doorstep to targeted therapy.
Prasad S; Ramachandran S; Gupta N; Kaushik I; Srivastava SK
Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165424. PubMed ID: 30818002
[TBL] [Abstract][Full Text] [Related]
39. miR-125a/b inhibits tumor-associated macrophages mediated in cancer stem cells of hepatocellular carcinoma by targeting CD90.
Wang Y; Wang B; Xiao S; Li Y; Chen Q
J Cell Biochem; 2019 Mar; 120(3):3046-3055. PubMed ID: 30536969
[TBL] [Abstract][Full Text] [Related]
40. Crosstalk between M2 macrophages and glioma stem cells.
Nusblat LM; Carroll MJ; Roth CM
Cell Oncol (Dordr); 2017 Oct; 40(5):471-482. PubMed ID: 28643230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
